Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.75 NOK | +5.47% | -0.74% | -43.75% |
04-19 | EXACT Therapeutics AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Exact Therapeutics Wins Regulatory Approvals for Patient Recruitment in Dose Expansion Study | MT |
Business Summary
Number of employees: 12
Sales per Business
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Acoustic Cluster Therapy
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -99.02% |
Sales per region
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Norway
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -99.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Svein Kvåle
FOU | Founder | - | 11-12-31 |
Per Walday
CEO | Chief Executive Officer | 64 | 22-03-27 |
John Edminson
DFI | Director of Finance/CFO | - | 22-09-30 |
Amir Snapir
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-20 |
Ragnar Bendiksen
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Corporate Officer/Principal | - | 10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Castell
BRD | Director/Board Member | 76 | 18-06-21 |
Director/Board Member | 57 | - | |
Director/Board Member | 53 | 14-12-31 | |
Anders Wold
CHM | Chairman | - | 21-12-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,080,552 | 10,360,704 ( 32.30 %) | 0 | 32.30 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-43.75% | 19.97M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- EXTX Stock
- Company EXACT Therapeutics